Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gratwohl

Showing results (331-340 of 381) with videos related to

Pageof 39
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemiaP Sonneveld, A Burnett, P Vossebeld, et al.
Leukemia|December 26, 2001
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantationT de Witte, F Pikkemaat, J Hermans, et al.
Blood|May 26, 1999
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMTE F Posthuma, J H Falkenburg, J F Apperley, et al.
Bone Marrow Transplantation|December 9, 2008
Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cellsS Meyer-Monard, J Passweg, C Troeger, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Bone Marrow Transplantation|January 31, 2006
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeP Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, et al.
Bone Marrow Transplantation|August 16, 2002
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeA Urbano-Ispizua, N Schmitz, T de Witte, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
British Journal of Haematology|September 21, 2000
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)T de Witte, J Hermans, J Vossen, et al.
Pageof 39

Showing results (331-340 of 381) with videos related to

Sort By:
Pageof 39
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemiaP Sonneveld, A Burnett, P Vossebeld, et al.
Leukemia|December 26, 2001
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantationT de Witte, F Pikkemaat, J Hermans, et al.
Blood|May 26, 1999
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMTE F Posthuma, J H Falkenburg, J F Apperley, et al.
Bone Marrow Transplantation|December 9, 2008
Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cellsS Meyer-Monard, J Passweg, C Troeger, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Bone Marrow Transplantation|January 31, 2006
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeP Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, et al.
Bone Marrow Transplantation|August 16, 2002
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeA Urbano-Ispizua, N Schmitz, T de Witte, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
British Journal of Haematology|September 21, 2000
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)T de Witte, J Hermans, J Vossen, et al.
Pageof 39